A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia
Yongquan Gu(Xuan Wu Hospital of the Capital Medical University), Yue Liu, Chang Shu(Central South University), Changjian Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Wei Guo(Yichang Central People's Hospital), Bi Jin(Wuhan Union Hospital), Tongbin Chu(Dalian Medical University), Qi Wang(Hebei Medical University), Changwei Liu(Hunan University of Science and Technology), Fuxian Zhang(Capital Medical University), Shijun Cui(Xuan Wu Hospital of the Capital Medical University), Chengquan Han
Cited by 46
Related Papers
Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study
|The Lancet Public Health|2020|1.8k
Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with β-amyloid deposits in Alzheimer’s disease
|Journal of Structural Biology|2005|585
Heritability and genomics of gene expression in peripheral blood
|Nature Genetics|2014|424
Multiple NF-κB Enhancer Elements Regulate Cytokine Induction of the Human Inducible Nitric Oxide Synthase Gene
|Journal of Biological Chemistry|1998|412
CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling
|Cell Death and Disease|2018|345